[ad_1]
Its US partner Pfizer and Prof. Dr. Uğur Şahin and Dr. The first application of the corona vaccine developed by BioNTech, founded by Özlem Türeci, is expected to begin on December 13 in the United States. The company is waiting for the vaccine to be approved by the FDA for the big day.
Prof. Dr. Uğur Şahin and Dr. American pharmaceutical company of the BioNTech company founded by Özlem Türeci PfizerPfizer CEO Albert Bourla, the company’s most authorized name, announced when the first vaccine application with was developed.
START 13 DECEMBERWILL START
US pharmaceutical giant Pfizer and Biontech approached the US Food and Drug Administration (FDA) for approval of the vaccine, which they developed against corona and announced it was 95% effective. DecemberIt is estimated to start in.
IT WILL BE DISTRIBUTED 24 HOURS AFTER APPROVAL
“Warp Speed Operation” President Moncef Slaoui, initiated by the Trump administration for Covid-19 vaccine studies, told CNN television: “We plan to send the vaccine to vaccination centers within 24 hours of approval. of the vaccine “. She said. Slaoui said he expected the approval to be finalized on 11 or 12 December. Vaccination procedures should begin with healthcare professionals first.
CEO ALBERT BOURLA ANNOUNCED THE STORY IN ONE DAY
Albert Bourla, CEO of US pharmaceutical giant Pfizer, said in the video released on Friday: “Today is a historic day, today is a historic day for science and for all of us. 248 days went by to question: From concept to license applications, we have always focused on safety, working at an unmistakable pace in our clinical development program.
BECOME THE FIRST COMPANY TO APPLY FOR A LICENSE IN THE USA
Pfizer was the first company in the United States to apply for a license for the corona virus vaccine. As stated today by Pfizer and BioNTech; The vaccine candidate, known as “BNT 162b2”, could potentially be used in high-risk population groups in the United States in mid-December.
.
[ad_2]
Source link
